SCHEMBL13104792

SCHEMBL13104792

CNc1ccc(-n2ncnn2)cc1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BRS3 P32247 1/20 0.35
TSHR P16473 1/20 0.34
APP P05067 3/20 0.32
ALDH1A1 P00352 2/20 0.31
RECQL P46063 2/20 0.31
HSD17B10 Q99714 2/20 0.31
CA12 O43570 1/20 0.31
CA1 P00915 1/20 0.31
CA2 P00918 1/20 0.31
TP53 P04637 1/20 0.31
CYP3A4 P08684 1/20 0.31
THRB P10828 1/20 0.31
HPGD P15428 1/20 0.31
ALOX15 P16050 1/20 0.31
CASP1 P29466 1/20 0.31
HIF1A Q16665 1/20 0.31
ADRA2A P08913 2/20 0.31
ADRA2B P18089 2/20 0.31
ADRA2C P18825 2/20 0.31
KIF11 P52732 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19567894 0.77 TSHR (0.39) TSHRAPPALDH1A1RECQLHSD17B10
SCHEMBL9440546 0.77 NOTUM (0.45) BRS3TSHRALDH1A1RECQLHSD17B10
SCHEMBL10134047 0.76 ALDH1A1 (0.41) BRS3ALDH1A1PDPK1
Hydrochloric Acid SCHEMBL4739527 0.75 NOTUM (0.44) BRS3TSHRALDH1A1RECQLHSD17B10
SCHEMBL7463145 0.72 BRS3 (0.35) BRS3PDPK1
SCHEMBL1186753 0.72 BRS3 (0.38) BRS3ALDH1A1RECQLHSD17B10TP53
SCHEMBL7400517 0.72 CYP2A6 (0.36) BRS3TSHRPDPK1
SCHEMBL2211763 0.72 KDM4E (0.46) BRS3TSHRALDH1A1HSD17B10HPGD
Bromide SCHEMBL28126767 0.70 KDM4E (0.44) BRS3TSHRALDH1A1HSD17B10HPGD
SCHEMBL10246310 0.68 CYP2C9 (0.52) TSHRAPPALDH1A1RECQLHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100267945-A1 AMINE DERIVATIVE HAVING NPY Y5 RECEPTOR ANTAGONISTIC ACTIVITY SHIONOGI & CO., LTD. (JP) 2010-10-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100267945-A1 AMINE DERIVATIVE HAVING NPY Y5 RECEPTOR ANTAGONISTIC ACTIVITY NPY5R, NPY1R, NPY2R BRS3 61/4885TSHR 92/4885APP 883/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.